BioSpace News Archive

Umoja Biopharma, Inc. and Lupagen, Inc. announced they have entered into a collaboration to evaluate extracorporeal in vivo delivery as a potential additional route of administration for Umoja’s VivoVec particles using Lupagen’s Side CAR-T™ technology.

IO Biotech announced that the Company will be participating in the Jefferies Global Healthcare Conference, to be held June 8-10, 2022, in New York City.

Blood screening and typing market focuses on screening and analysis of donor blood and patient blood, respectively.

Albany NY, United States: Skin rash is not a medical condition but a symptom of skin inflammation and discoloration caused by some kind of infection.

Albany NY, United States: Shockwave lithotripsy is a non-invasive procedure of breaking kidney stones that are too large to pass through the urinary tract.

Albany NY, United States: The rise in beauty standards worldwide is likely to add as a notable factor boosting the global liposuction surgery devices market during the forecast period, 2020 to 2030.

Calibre Scientific is pleased to announce the acquisition of Serviquimia, a high-quality distributor of consumables, chemicals, lab equipment, and lab furniture, headquartered in Tarragona, Spain.

Exavir Therapeutics, a company dedicated to transforming the lives of people living with or at risk of acquiring HIV, today announced that the company has closed on a $4M seed financing led by AlleyCorp with participation from Gilead Sciences.

Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide) nasal spray, today announced the presentation of a real-world data analyses demonstrating a lower risk of tardive dyskinesia (TD) associated with metoclopramide usage compared to previous reports at the world’s premier gastroenterology conference.

First patients dosed in study sub-part evaluating BND-22 in combination with pembrolizumab or with cetuximab.